First-in-human phase 1/2a study of the novel nonfucosylated anti-CTLA-4 monoclonal antibody BMS-986218 +/- nivolumab in advanced solid tumors: Initial phase 1 results Meeting Abstract
| Authors: | Friedman, C.; Ascierto, P.; Davar, D.; O'Hara, M.; Shapira-Frommer, R.; Dallos, M.; Khemka, V.; James, L.; Fischer, B.; Demes, S.; Li, L.; Kozicki, M.; Ravindran, P.; Xu, K.; Kollia, G.; Shoukry, J.; Yunan, M.; Massey, A.; Gutierrez, M. |
| Abstract Title: | First-in-human phase 1/2a study of the novel nonfucosylated anti-CTLA-4 monoclonal antibody BMS-986218 +/- nivolumab in advanced solid tumors: Initial phase 1 results |
| Meeting Title: | 35th Annual Meeting of the Society for Immunotherapy of Cancer (SITC) |
| Journal Title: | Journal for ImmunoTherapy of Cancer |
| Volume: | 8 |
| Issue: | Suppl. 3 |
| Meeting Dates: | 2020 Nov 9-14 |
| Meeting Location: | Virtual |
| ISSN: | 2051-1426 |
| Publisher: | Biomed Central Ltd |
| Date Published: | 2020-11-01 |
| Start Page: | A239 |
| Language: | English |
| ACCESSION: | WOS:000616665300382 |
| DOI: | 10.1136/jitc-2020-SITC2020.0393 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 393 -- Source: Wos |
